Fresenius Kabi USA, LLC Xylocaine , 1%, 200 mg per 20 mL , 25 Multiple-Dose Vials recall: Presence of Particulate Matter: Hair was found in products
Presence of Particulate Matter: Hair was found in products
The hazard: Sterility or particulate concern
Particulate matter or a sterility failure prompted this notice, the most common reason injectable and ophthalmic products are withdrawn.
What the notice says: Presence of Particulate Matter: Hair was found in products
Why it matters: The product was made or packaged in conditions that cannot assure sterility, or visible particles were found in it. For anything injected, infused or used in the eye, that is a direct route for contamination into the body.
Symptoms and when to call a doctor
Watch for fever, chills, pain, redness, swelling or discharge at an injection site, and for a red, painful or suddenly blurred eye after using an eye product. Any of these needs same-day medical attention. Do not wait to see whether it settles, and tell the clinician which product and lot you used so it can be reported against the recall.
This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.
Recall details
- Recall number
- D-0728-2026
- Published
- July 29, 2026
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Fresenius Kabi USA, LLC
- Product type
- Prescription & OTC drugs
- Units affected
- 93,250 vials
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- Lot #: 6130235, Exp. Date 02/2027
Products covered by this recall
Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vials, 20 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-27; NDC Vial: 63323-485-01
Check your product
The notice names 9 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- 6130235
- 2027 — 93
- 250 vials
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- 02
- 2027 — 93
- 250 vials
Package size
Match the net weight or the piece count on the front of the pack.
- 200 mg
- 20 mL
- 10 mg
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Sterility
Fresenius Kabi USA, LLC — Particulate matter or a sterility failure prompted this notice, the most common reason injectable and ophthalmic products are withdrawn.
- Stop using the affected lot and check the lot number on your own carton or vial against the codes listed above.
- Report any infection or reaction you think the product caused to FDA MedWatch.
- Do not use a vial or syringe with visible particles, cloudiness or discolouration, whether or not it is on the recall list.
- Call your prescriber or pharmacy today about a replacement from an unaffected lot — do not simply skip doses of a medicine you depend on.
What the company owes you
A recalled medicine is the manufacturer’s cost to carry, not yours or your pharmacist’s.
- The purchase price or co-pay is refundable, and so is the cost of returning the product if they ask you to ship it.
- Ask the pharmacy to handle the claim where they can — they process recall returns in bulk and it saves you the correspondence.
- Keep the carton, the leaflet and the pharmacy label together until the claim is closed.
- Costs beyond the price of the medicine need to go to the company directly, in writing, with the recall number quoted.
Company contact: Fresenius Kabi USA, LLC — 3 Corporate Dr, Lake Zurich, IL, 60047-8930
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Fresenius Kabi USA, LLC prescription & otc drugs recalled?
Presence of Particulate Matter: Hair was found in products Presence of Particulate Matter: Hair was found in products
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code 6130235, 2027 — 93, 250 vials; best-by date 02 or 2027 — 93. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Stop using the affected lot and check the lot number on your own carton or vial against the codes listed above.
Can I get my money back?
The purchase price or co-pay is refundable, and so is the cost of returning the product if they ask you to ship it.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class I · last month
Fresenius Kabi USA, LLC Tyenne Injection, 400 mg/20 mL , 20 mL vial recall: Presence of particulate matter:An internal investigation at the firm found
Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.
-
Class I · 2 months ago
Fresenius Kabi USA, LLC Morphine Sulfate Injection, USP, 2 mg /mL recall: Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL
Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.
-
Class II · 3 months ago
Fresenius Kabi USA, LLC Naropin , 0.5%, 100 mg per 20 mL , Twenty-five recall: Presence of Particulate Matter: Hair was found in products
Presence of Particulate Matter: Hair was found in products
-
Class II · 3 months ago
Fresenius Kabi USA, LLC Lidocaine HCl Injection, USP, 2%, 100 mg per 5 mL recall: Presence of Particulate Matter: Hair was found in products
Presence of Particulate Matter: Hair was found in products
-
Class II · 3 months ago
Fresenius Kabi USA, LLC Xylocaine , 1%, 500 mg per 50 mL , 25 Multiple-Dose Vials recall: Presence of Particulate Matter: Hair was found in products
Presence of Particulate Matter: Hair was found in products
-
Class II · 3 months ago
Fresenius Kabi USA, LLC Glycopyrrolate Injection, USP, 1 mg per 5 mL recall: Presence of Particulate Matter: Hair was found in product
Presence of Particulate Matter: Hair was found in product